TAIWANJ PHARMACEUTICALS CO., LTD.

Patent Applications and Registrations

Patent applications and USPTO patent grants for TAIWANJ PHARMACEUTICALS CO., LTD..The latest application filed is for "peripheral alkyl and alkenyl chains extended benzene derivatives and pharmaceutical composition including the same".

Company Profile

8.9.22

TAIWANJ PHARMACEUTICALS CO., LTD. - Zhubei City, Hsinchu County TW
TAIWANJ PHARMACEUTICALS CO., LTD. - Zhubei N/A TW
TAIWANJ PHARMACEUTICALS CO., LTD. - Zhubei City TW
TAIWANJ PHARMACEUTICALS CO., LTD - Zhubei City, Hsinchu County TW
TAIWANJ PHARMACEUTICALS CO., LTD. - Zhubei, Hsinchu County N/A TW
TaiwanJ Pharmaceuticals Co., Ltd. - Chu-Pei TW
TaiwanJ Pharmaceuticals Co., Ltd. - Zhubel TW

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Peripheral Alkyl And Alkenyl Chains Extended Benzene Derivatives And Pharmaceutical Composition Including The Same App 20220153687 - YANG; Syaulan S. ; et al.	2022-05-19
Prodrugs of Naltrexone, Nalmefene and derivatives thereof Grant 11,130,771 - Yang , et al. September 28, 2	2021-09-28
Nadph Oxidase Inhibitors, Pharmaceutical Composition Comprising The Same, And Application Thereof App 20210276957 - YANG; Syaulan S. ; et al.	2021-09-09
Prodrugs Of Naltrexone, Nalmefene And Derivatives Thereof App 20210261579 - YANG; Syaulan S. ; et al.	2021-08-26
Benzene fused heterocyclic derivative and pharmaceutical composition comprising the same Grant 11,091,421 - Yang , et al. August 17, 2	2021-08-17
Morphinan Derivatives And Compositions Comprising The Same For Treating Autoimmune, Inflammation Or Infection Related Disorders App 20210130316 - YANG; Syaulan S. ; et al.	2021-05-06
Pharmaceutical Formulation For A Solid Dosage Form Of Opioid Receptor Antagonists App 20200352867 - YANG; Syaulan S. ; et al.	2020-11-12
Sulfonamide Or Amide Compounds, Compositions And Methods For The Prophylaxis And/or Treatment Of Autoimmune, Inflammation Or Inf App 20200247761 - Kind Code	2020-08-06
Benzene Fused Heterocyclic Derivative And Pharmaceutical Composition Comprising The Same App 20200190010 - YANG; Syaulan S. ; et al.	2020-06-18
Benzene Fused Heterocyclic Compound And Use Thereof App 20200157088 - YANG; Syaulan S. ; et al.	2020-05-21
Use Of Nalmefene In Non-alcoholic Steatohepatitis App 20180318290 - Chiu; Peter J.S. ; et al.	2018-11-08
Use of nalmefene in non-alcoholic steatohepatitis Grant 10,045,977 - Wu , et al. August 14, 2	2018-08-14
Use Of Nalmefene In Non-alcoholic Steatohepatitis App 20170304294 - WU; Edwin SC ; et al.	2017-10-26
Opioid and opioid-like compounds and uses thereof Grant 9,776,971 - Wu , et al. October 3, 2	2017-10-03
Toll-like receptor 4 antagonists and use in autoimmune liver diseases Grant 9,757,372 - Chiu , et al. September 12, 2	2017-09-12
Toll-like Receptor 4 Antagonists And Use In Autoimmune Liver Diseases App 20160287578 - CHIU; Peter JS ; et al.	2016-10-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.